BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3685079)

  • 1. Inhibitors of histidine decarboxylase decrease basal gastric acid secretion in the rat.
    Westerberg VS; Geiger JD
    Pharmacol Biochem Behav; 1987 Nov; 28(3):419-22. PubMed ID: 3685079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Fluoromethyl histidine. Inhibition of histidine decarboxylase in pylorus ligated rat.
    Bouclier M; Jung MJ; Gerhart F
    Biochem Pharmacol; 1983 May; 32(10):1553-6. PubMed ID: 6860344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prolonged inhibition of histidine decarboxylase on tissue histamine concentrations.
    Bouclier M; Jung MJ; Gerhart F
    Experientia; 1983 Nov; 39(11):1303-5. PubMed ID: 6641910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histidine decarboxylase inhibition: a novel approach towards the development of an effective and safe gastric anti-ulcer drug.
    Parmar NS; Hennings G; Gulati OP
    Agents Actions; 1984 Dec; 15(5-6):494-9. PubMed ID: 6397982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of His-Phe, a competitive inhibitor of histidine decarboxylase, on gastric acid secretion in chronic gastric fistula rats: delay in acid secretion response to pentagastrin.
    Mattsson M; Henningsson AC; Henningsson S; Hammar L
    Agents Actions; 1982 Apr; 12(1-2):176-8. PubMed ID: 7080954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked inhibition of histamine formation in transplantable histamine-producing gastric carcinoid of Mastomys natalensis by (S)-alpha-fluoromethylhistidine and its potent antiulcer effect on tumor-bearing hosts.
    Hosoda S; Saito T; Kumazawa H; Watanabe T; Wada H
    Biochem Pharmacol; 1985 Dec; 34(24):4327-9. PubMed ID: 4074392
    [No Abstract]   [Full Text] [Related]  

  • 7. alpha-fluoromethylhistidine depletes histamine from secreting but not from non-secreting rat stomach ECL cells.
    Norlén P; Lindström E; Zhao C; Kitano M; Chen D; Andersson K; Håkanson R
    Eur J Pharmacol; 2000 Jul; 400(1):1-10. PubMed ID: 10913579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alpha-fluoromethylhistidine, a suicide inhibitor of histidine decarboxylase, on histamine levels in mouse tissues.
    Maeyama K; Watanabe T; Taguchi Y; Yamatodani A; Wada H
    Biochem Pharmacol; 1982 Jul; 31(14):2367-70. PubMed ID: 7126249
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of gastric histamine synthesis by H2-receptor antagonists: potentiation of their antisecretory activity by histidine decarboxylase inhibitors.
    Huszti Z; Pik K; Frenkl R
    Agents Actions; 1980 Sep; 10(4):302-8. PubMed ID: 6108701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of two inhibitors of histidine decarboxylase on gastric secretion in the rat.
    Megazzini P; Bacciarelli C
    Arzneimittelforschung; 1977; 27(3):620-3. PubMed ID: 577431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histidine uptake by isolated rat peritoneal mast cells. Effect of inhibition of histidine decarboxylase by alpha-fluoromethylhistidine.
    Bauza MT; Lagunoff D
    Biochem Pharmacol; 1983 Jan; 32(1):59-63. PubMed ID: 6830620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of histamine biosynthesis and gastric function in the rat: effect on pentagastrin-induced gastric acid secretion.
    Bouclier M; Jung M; Gerhart F
    Agents Actions; 1983 Apr; 13(2-3):241-6. PubMed ID: 6869126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on mast cell histamine of inhibiting histamine formation in vivo with alpha-fluoromethylhistidine.
    Lagunoff D; Ray A; Rickard A
    Biochem Pharmacol; 1985 Apr; 34(8):1205-9. PubMed ID: 3994743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gastric anti-ulcer activity of naringenin, a specific histidine decarboxylase inhibitor.
    Parmar NS
    Int J Tissue React; 1983; 5(4):415-20. PubMed ID: 6671888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha-fluoromethylhistidine (FMH), an irreversible inhibitor of histidine decarboxylase, on development of brain histamine and catecholamine systems in the neonatal rat.
    Slotkin TA; Slepetis RJ; Weigel SJ; Whitmore WL
    Life Sci; 1983 Jun; 32(25):2897-903. PubMed ID: 6855476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of histidine-decarboxylase inhibitors on gastric acid secretion in the rat.
    Castellucci A; Megazzini P
    Arzneimittelforschung; 1976; 26(1):62-5. PubMed ID: 947180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of inactivation of mammalian L-histidine decarboxylase by (S)-alpha-fluoromethylhistidine.
    Kubota H; Hayashi H; Watanabe T; Taguchi Y; Wada H
    Biochem Pharmacol; 1984 Apr; 33(7):983-90. PubMed ID: 6712729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric protection by meciadanol. A new synthetic flavonoid inhibiting histidine decarboxylase.
    Konturek SJ; Kitler ME; Brzozowski T; Radecki T
    Dig Dis Sci; 1986 Aug; 31(8):847-52. PubMed ID: 3525045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of histamine synthesis in brain by alpha-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies.
    Garbarg M; Barbin G; Rodergas E; Schwartz JC
    J Neurochem; 1980 Nov; 35(5):1045-52. PubMed ID: 7452304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histidine decarboxylase inhibition by O-methyl-3(+)catechin and gastric acid secretion in the cat.
    Albinus M; Frisch G; Hennings G
    Agents Actions; 1983 Apr; 13(2-3):249-51. PubMed ID: 6869127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.